These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
128 related items for PubMed ID: 7333068
1. [Effect of the administration of silymarin on serum lipid levels]. Petronelli A, Roda E, Briganti M, Morselli Labate AM, Barbara L. Clin Ter; 1981 Dec 15; 99(5):471-82. PubMed ID: 7333068 [No Abstract] [Full Text] [Related]
2. [Rapid changes in blood lipid parameters induced by glucuronyl glucosamine glycan sulfate in obese diabetic and hyperlipidemia patients]. Ferlito S, La Spina E, Fichera C, Cultrera E, Patanè M, Ciulla P. Arch Sci Med (Torino); 1982 Dec 15; 139(4):441-8. PubMed ID: 7168636 [No Abstract] [Full Text] [Related]
3. [Sulfinpyrazone and lipoproteins: absence of effects on serum lipids in hyperlipoproteinemias of types II and IV]. Sommariva D, Scotti L, Baroni L, Beggi P, Fasoli A. Clin Ter; 1980 Mar 31; 92(6):649-55. PubMed ID: 7460493 [No Abstract] [Full Text] [Related]
4. [Effect of procetofen on lipoproteins and blood lipids in patients with hyperlipemia]. Abaurre R, Vega J, Maneschi E, Bernabe H. Medicina (B Aires); 1980 Mar 31; 40(6 Pt 2):896. PubMed ID: 7219169 [No Abstract] [Full Text] [Related]
6. [Behavior of serum lipids, blood coagulation factors, platelet aggregation, complement and serum immunoglobulins in a group of arteriosclerotic, hyperlipemic subjects treated with 3GS]. D'Eredità F, Avellone G, Novo S, Davì G, Abruzzese G, Di Liberti M, Pinto A, Riolo F. Clin Ter; 1981 Feb 15; 96(3):303-24. PubMed ID: 7307448 [No Abstract] [Full Text] [Related]
7. [Evaluation of the effectiveness of gemfibrozil in primary dyslipoproteinemias. I. Changes in lipid levels after treatment (the "net" reduction)]. Sznajd J, Malczewska-Malec M, Idzior-Waluś B, Jamska B, Nowacki G. Przegl Lek; 1987 Feb 15; 44(12):828-36. PubMed ID: 3330252 [No Abstract] [Full Text] [Related]
9. [Bile lipid composition in subjects with blood lipid disorders (types II and IV). Effect of a new hypolipemic drug (Etofibrate)]. Altomonte L, Mingrone G, Ghirlanda G, Manna R, Rebuzzi A, Pala MA, Greco AV. Minerva Med; 1980 Feb 11; 71(4):273-8. PubMed ID: 7354946 [Abstract] [Full Text] [Related]
10. The effect of I.V. glucagon administration on selected metabolic parameters in patients with type IIa, IIb and IV primary hyperlipoproteinaemia. Andĕl M, Brodan V, Kucerová L, Brodanová M. Acta Univ Carol Med (Praha); 1980 Feb 11; 26(5-6):271-92. PubMed ID: 7347126 [No Abstract] [Full Text] [Related]
11. [Effect of silymarin on serum lipoproteins in hyperlipemic rats]. Mai K. Zhonghua Xin Xue Guan Bing Za Zhi; 1987 Feb 11; 15(1):49-51. PubMed ID: 3608787 [No Abstract] [Full Text] [Related]
12. Preliminary results of sulodexide treatment in patients with peripheral arteriosclerosis and hyperlipidemia. A multicentre trial. Crepaldi G, Fellin R, Calabrò A, Baiocchi MR, Rossi A, Lenzi S, Descovich GC, Delmonte G, Gaddi A, Ventura A. Monogr Atheroscler; 1986 Feb 11; 14():215-21. PubMed ID: 3526129 [No Abstract] [Full Text] [Related]
20. [Effects of polyenylphosphatidylcholine (PPC) on serum lipids in patients with hyperlipoproteinemia. A double-blind study]. Horsch AK, Majolk I, Heuck CC, Göpfert E. Vasa; 1986 Feb 11; 15(3):251-5. PubMed ID: 3532609 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]